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Purpose: To determine clinical phenotypes, examine the age dependency of X-linked juvenile retinoschisis (XLRS), and
identify mutations in the retinoschisis1 gene (RS1) in 13 Hungarian (Caucasian) families with this disease.
Methods: This study included 72 members in 13 families. Complete ophthalmological examinations, including optical
coherence tomography (OCT) and full-field and multifocal electroretinography (ERG), were performed on 20 affected
males, 13 female carriers, and 27 healthy controls. The patients were divided into two age groups (Group I <25 years and
Group II >25 years), retrospectively, to assess the possible effects of age. Correlations among genotype, age, best corrected
visual acuity (BCVA), OCT, and ERG results were analyzed. A modified classification scheme was done to identify the
different phenotypes of the disease. In each of the 72 family members and 100 age-matched male controls, all exons and
introns of RS1 were amplified by polymerase chain reaction (PCR) and directly sequenced.
Results: Foveal retinoschisis was detected in 25 eyes (62.5%) of patients by funduscopy, and in 29 eyes (72.5%) by OCT,
while macular lamellar schisis was recognizable only by OCT in 30 eyes (75%) of patients. Foveal thickness (FT) and
total macular volume were significantly increased in younger (Group I) patients only. For patients younger than 26 years,
large inner nuclear central cysts were observable by OCT, while after 26 years, foveas were atrophic. White flecks and
dots, which were like that seen in fundus albipunctatus, were detected in both eyes of one patient. In both patient groups,
characteristically decreased b-waves of standard combined ERG were recorded without any significant difference between
the patient groups. The BCVA and ERG parameters of all patients and the OCT of younger patients were significantly
worse (p<0.05) than those of age-matched controls. A significant difference between the two age groups was found in
case FT, total macular volume, and amplitudes of rod b-wave only. Moderate negative correlation (r=-0.54, p<0.001) was
detected between age and FT, while only low negative correlation (r=-0.33, p<0.05) was detected between age and standard
combined b-wave amplitudes of full-field ERG. BCVA LogMAR did not show any obvious correlation with age (r=-0.14,
p=0.39) or with the type of mutation. Nine different mutations were identified in 25 male patients and 31 female carriers
of 13 families: six known and one novel missense mutation (c.575C>T, p.Pro192Leu), one insertion mutation (c.579dupC,
p.Ile194Hisfs29ext43), and one frameshift, causing splice site mutation (c.78+1G>C) were detected. These mutations
were absent in the 100 age-matched male control samples.
Conclusions: Foveal cystic schisis was found more often by OCT than by funduscopy (+10%), while flat macular lamellar
schisis was recognizable only by OCT. Advancing age inversely influenced the size of cavities (FT), and standard
combined  b-wave  amplitudes  of  full-field  ERG,  while  BCVA,  response  density,  and  implicit  times  of  multifocal
electroretinography did not show any obvious correlation with age. The atrophic stage of the disease was observable after
26 years of age. The lesions that appeared to be indicative of fundus albipunctatus were proven to be palisades between
the splitted retinal layers. Our modified classification scheme was helpful in assessing the prevalence of disease types. In
these Hungarian patients, one novel and eight known mutations were detected. The distribution of mutations in RS1 was
different to that reported in the literature, because the greatest number of different mutations was in exon 6 instead of exon
4. Two mutation hot spots were found: between c.418–422 in exon 5 and between c.574–579 in exon 6. Genotype-
phenotype correlation was not demonstrable.
X-linked juvenile retinoschisis (XLRS; OMIM: 312700)
is one of the most common X-linked recessively inherited,
bilateral,  progressive  vitreoretinal  dystrophies.  Limited
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almost exclusively to males, the incidence is between 1:5,000
and 1:25,000 [1–3]. Macular changes are present in almost all
cases  [4].  In  the  fundi,  radially  oriented  intraretinal
foveomacular cysts are seen in a spoke-wheel configuration,
with the absence of foveal reflex in most cases (Figure 1A).
In  addition,  approximately  half  of  cases  have  bilateral
peripheral retinoschisis in the inferotemporal part of the retina
(Figure 1B) [4]. Aside from the typical fundus appearance,
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2321strabismus,  nystagmus,  axial  hyperopia,  defective  color
vision (red-green dyschromatopsia) and foveal ectopy can be
present [4,5]. The most important complications were vitreous
hemorrhage, retinal detachment, and neovascular glaucoma
[1,4,6]. The diagnosis of the disease is most often made in
boys aged 5–10 years, who may also exhibit symptoms of
uncorrectable visual disturbance and reading difficulties [4].
Optical  coherence  tomography  (OCT)  images  can  be
variable depending on the disease stage. The cysts are located
in different layers of the retina (Figure 1C), namely the nerve
fiber (NFL), ganglion cell (GCL), inner nuclear (INL), outer
plexiform  (OPL),  outer  nuclear  (ONL)  and  photoreceptor
layers (PRL) [7–9]. In the course of time the coalescing cysts
form a large central cavity (Figure 1C), which can pass into a
nonspecific macular atrophy (Figure 1D) [3,5,10,11]. Disease
severity and progression are highly variable.
Full-field  electroretinograms  (ERGs)  of  the  affected
individuals are characterized by predominant reduction of
standard combined b-wave amplitude (negative-type ERG: b-
wave to a-wave ratio less than or equal to 1) in the dark-
adapted eye (Figure 1E) [2,12]. The a-wave may also be
reduced with disease progression due to the increasing retinal
pigment  epithelium  (RPE)  atrophy  [4,13].  The  response
densities of multifocal ERG (mfERG) diminish mainly in the
central rings (Figure 1F) and the implicit times are extended.
Thus, ERG is a useful diagnostic method in almost all cases
[2].
XLRS  is  caused  by  mutation  in  the  RS1  gene
(localization:  Xp22.2-p22.1,  GenBank  AF014459),  which
was identified by positional cloning in 1997 (Figure 2) [14].
This is the only known gene to be associated with XLRS so
far [15]. RS1 has six exons and encodes a 224 amino acid (AA)
secretable extracellular adhesion protein, called retinoschisin
(RS1), which is primarily present in photoreceptors and in
bipolar cells [6]. It may be involved in cellular adhesion and
cell-cell  interactions  on  membrane  surfaces  [16].
Retinoschisin includes a secretory leader sequence (LS; 23
AA), an Rs1 domain (Rs1D; 39 AA), a highly conserved
discoidin domain (a main structural feature of RS; 157 AA),
and a C-terminal segment (5 AA) [2,16–19]. The discoidin
domain is essential for the normal development of the retina,
and if functional RS1 is lacking, schisis develops in different
retinal layers [14,15].
METHODS
Informed consent was obtained from all participants after a
full explanation of the nature and possible consequences of
the study. All studies were conducted in accordance with the
tenets  of  the  Declaration  of  Helsinki.  Molecular  genetic
examinations were approved by the Ethics Committee for
Human Genome Research of Semmelweis University.
Patient and control groups: In all, 72 members (mean age
±SD:  32.6±19.1  years)  in  13  Hungarian  families  were
involved in the present study (Figure 3). Of the 72 family
members, 20 male patients (mean age ±SD: 24.5±16.8 years)
and  13  asymptomatic  female  carriers  (mean  age±SD:
37.7±13.3 years) took part in all clinical examinations: visual
acuity  tests,  indirect  ophthalmoscopy,  slit  lamp
biomicroscopy, full-field and mfERG, and OCT. The patients
were divided into two groups (Group I aged <25 years and
Group II aged >25 years), retrospectively, on the basis of our
observation that the cystic form of the disease manifest before
26 years of age, while the atrophic form occurs after 26 years
(Appendix 1, Figure 4). In this way we could examine the
possible functional effects of morphological changes and the
effects  of  age.  All  72  family  members  participated  in
molecular genetic examinations.
A  control  group  of  27  healthy  age-matched  normal
subjects (mean age ±SD: 20.1±8.2 years) was examined using
the same clinical protocol. To confirm the pathogenetic effects
of the identified mutations a control group of 100 healthy age-
matched  normal  male  subjects  (mean  age±SD:  22.4±9.3
years)  was  examined  using  the  same  molecular  genetic
protocol.  BCVA  logarithm  of  the  Minimum  Angle  of
Resolution=logarithm of the reciprocal of Snellen’s fraction
(LogMAR  units)  was  0.0  in  all  controls,  and  no  visual
disturbances were found.
Clinical examinations: All study participants underwent
standard  ophthalmological  examinations.  BCVA  was
determined  using  the  Snellen  chart  then  converted  to
LogMAR  units.  Dilated  indirect  ophthalmoscopy  of  the
posterior pole and the periphery was performed with fundus
photography.
Optical coherence tomography: OCT was performed in
both eyes of the family members using six 6 mm long OCT
scans centered on the fovea by a Stratus OCT device (Carl
Zeiss Medical Inc., Dublin, CA). The foveal thickness (FT)
was measured manually in the center of the fovea with the
more accurate caliper technique, while total macular volume
(TMV) was calculated automatically by the built-in software
of the device. To determine eccentric fixation, we displayed
the FT on a color-coded map; the center of the map showed
the fixation point (Figure 1C-D). To assess the prevalence of
the  different  phenotypes  of  the  disease,  we  modified  and
extended  the  Prenner  “Classification  scheme  for  XLRS”
(Table 1) [20].
Electroretinography:  For  each  subject,  ERG  was
performed  (RetiPort  ERG  system,  Roland  Consult,
Wiesbaden,  Germany)  using  corneal  “jet”  contact  lens
electrodes,  according  to  International  Society  for  Clinical
Electrophysiology of Vision (ISCEV) standards. Amplitudes
and implicit times of scotopic and photopic full-field ERG
responses were measured, and the ratio of standard combined
b- and a-wave amplitudes was calculated. During mfERG the
central  60°  diameter  part  of  the  retina  was  stimulated
monocularly by 61 hexagons shown on a 21” CRT display,
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2322Figure 1. Characteristic signs of XLRS. A: Fundus photograph of patient IV:2 of family 1 showing foveal schisis with spoke-wheel pattern. B:
Fundus photograph of left eye of patient III:3 of family 3 showing bullous infero-temporal retinoschisis. C: OCT image (scan length: 6 mm,
horizontal section) of patient IV:2 of family 1 showing foveal cystic retinoschisis in three different retinal layers (marked by red arrows) and
the color-coded foveal thickness maps showing the eccentric fixation. GCL indicates ganglion cell layer, INL represents inner nuclear layer
and PRL refers photoreceptor layer. D: OCT image of patient III:2 of family 5 showing foveal atrophy and the color-coded foveal thickness
map showing the eccentric fixation. E: Standard combined response of full-field ERG showing decreased b-wave amplitude (“negative type”
ERG) related to normal (see red arrow). F: Multifocal ERG with 61 first-order kernels showing decreased b-(P1) wave amplitudes in the
central rings (marked by red).
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2323under photopic conditions. Amplitudes and implicit times of
the b-waves (P1) of first order kernels (FOK) were measured.
For each patient, response densities (RD; nV/deg2) in the five
concentric  rings  were  calculated.  All  the  amplitudes  and
implicit times were compared with the mean values±SD of the
normal age-matched controls.
Genetic examination: Genomic DNA was extracted from
peripheral blood leucocytes using the QIAamp DNA Mini Kit
(Qiagen GmbH, Hilden, Germany). PCR was performed using
standard protocols in a Thermo Hybaid PxE thermal cycler
(Thermo Hybaid, Franklin, MA) with oligonucleotide primers
published  previously  by  the  RS  Consortium  [15].  The
amplicons were analyzed on 1% agarose gels and stained with
ethidium bromide and purified using Roche High Pure PCR
Purification  Kit  (Roche  Diagnostics  GmbH,  Mannheim,
Germany) according to the manufacturer’s protocol. Exons
and the flanking intronic regions of RS1 was sequenced by
direct nucleotide sequencing using the Big Dye Terminator
Cycle-Sequencing v3.1 Kit (Applied Biosystems, Foster City,
CA) and run on an automated sequencer (ABI PRISM® 310
Genetic Analyzer, Perkin Elmer™; Applied Biosystems). The
results were compared with the reference sequence of the X-
linked retinoschisis sequence variation database (dmd).
Statistical  analysis:  To  assess  significant  changes
between patients and control persons, we performed ANOVA
(one-way ANOVA) followed by Newman-Keuls post hoc
analysis.  Significance  was  accepted  at  the  p<0.05  level.
Correlations (Spearman rank) were calculated between age,
BCVA, OCT, and ERG parameters. For statistical analysis the
Statistica  6.0  (Statsoft,  Inc.,  Tulsa,  OK)  and  Excel
(Microsoft® Corp.) software packages were used.
Figure 2. Identified mutations, their frequency in the RS1 gene, and the retinoschisis protein. In the gene diagram, exons are represented by
bars (gray numbers indicate their numbers; black numbers indicate their size in nucleotides), and introns by lines. Mutations and their
localizations in the gene and the protein are marked by gray lines. In the protein diagram, leader sequence is abbreviated LS. Frequency of
different types of mutations within each exon and intron are indicated by red bars.
TABLE 1. CLASSIFICATION SCHEME OF XLRS
Foveal cystic schisis
(clinical and OCTexam)
Macular
lamellar schisis
(OCT exam)
Peripheral
schisis
(clinical exam)
BCVA
LogMAR
(mean±SD)
Prevalence
(percent)
Cystic                 Type 1 Foveal + - - 0.22 2.5
Type 2 Lamellar - + - 0.25±0.07 5
Type 3 Foveolamellar + + - 0.38±0.13 57.5
Type 4 Complex + + + 0.47±0.17 12.5
Type 5 Foveoperipheral + - + - -
Type 6 Peripheral - - + 0.85±0.21 5
Atrophic Type 7 Nonspecific - - - 0.28±0.26 17.5
The table shows the modified classification scheme of XLRS to assess the different phenotypes [20]. The scheme of classification
was devised that incorporated both clinical and OCT findings. There are 6 cystic subtypes and the atrophic type. Type 3 was
the most common phenotype of the disease. The prevalence of phenotypes is based on 40 eyes from 20 patients having XLRS.
The 2.5 value of prevalence is equal to 1 eye. SD represents standard deviations.
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XLRS form TypeRESULTS
Clinical examination: Table 1, Table 2, Table 3, Appendix
1, and the figures show the results of the clinical and molecular
genetic examinations. Although impairment of BCVA was
significant (p<0.05) in patients (Appendix 1) compared with
the normal age-matched controls, there was no significant
difference between the two patient groups. Foveal ectopy
were detected in 17 eyes of 12 male patients. During a one-
year follow-up only four eyes of two male patients (family 1
IV:2, family 2 III:1) showed improvement in BCVA from
0.42±0.17 to 0.27±0.13 (mean±SD). All XLRS patients had
macular abnormalities seen by indirect funduscopy. Eleven of
20 patients (55%) had typical bilateral foveal schisis, 25 of 40
eyes (62.5%) had typical microcystic findings (spoke-wheel
pattern; Figure 1A), and 15 eyes (37.5%) had nonspecific
atrophic macular degeneration. In addition to the macular
changes, peripheral retinoschisis was found only in seven eyes
(17.5%) in the inferotemporal part of the retina (Figure 1B).
White flecks and dots, characteristic of fundus albipunctatus,
were found in two eyes of patient III:3 in family 3, and this
feature was associated with the biggest foveal retinoschisis
and  huge  bullous  peripheral  retinoschisis  (Figure  1B  and
Figure  3.  Pedigrees  of  13  Hungarian  families  with  XLRS  and
identified mutations in the RS1 gene. Black boxes represent affected
males, while circles with a black dot in the center represent carrier
females by sequence analysis. Circles with an open dot represent
females those who are expected to be obligate carrier females. Red
arrows  point  to  probands.  Slashed  boxes  are  deceased  family
members. Blue stars mark family members who underwent complete
clinical examinations. The mutation screening of RS1 was performed
in all family members except probable XLRS carriers, who did not
want or could not take part in the study. Patients II:2 and II:3 in family
2 are fraternal twins, while patients II:3 and II:4 in family 12 are
identical twins.
Figure  5).  The  distance  between  white  flecks  and  dots
(calculated by fundus photography) was equal to the distance
between  palisades  connecting  the  splitted  retinal  layers
(measured by OCT).
Optical Coherence Tomography: Presence of cysts (any kind)
was evident in 31 eyes (77.5%), 29 eyes (72.5%) had foveal
cystic schisis, and 30 eyes (75%) had macular lamellar schisis.
The nonspecific atrophic form in the macula (without any
cystic changes) was found in 9 eyes (22.5%=type 6+7; Table
1). The most common appearance of the disease was the
combined foveal cystic and macular lamellar schisis (type 3,
23 eyes, 57.5%). BCVA impaired gradually from type 1 to
type 6.
The  most  extended  foveal  schisis  with  large,  low-
reflective cysts—surrounded perifoveally by many smaller
ones—was located in the INL (Figure 1C). The INL was
always affected in the cystic stage of the disease. Besides
these,  another  deeper  schisis  was  demonstrated  in  the
photoreceptor layer (PRL), and some small cysts were seen in
the GCL. Schisis was detected as follows: in 13 eyes (32.5%)
in the GCL, INL, and PRL; in 13 eyes (32.5%) in the GCL
and INL; in four eyes (10%) in the INL only; and in one eye
(2.5%) in the INL and PRL (Table 2). The worst BCVA values
were detected when cysts were located in the GCL, INL, and
PRL (Group A). In case affectedness of PRL in group A,
significant  impairment  of  BCVA  values  were  detected
compared with group B (p<0.05).
The FT was significantly increased in the macula in age-
group I (mean of FT±SD: 566.9±324.9, p<0.001), but there
was no significant increase in age-group II (mean of FT±SD:
210.9±191.8) as compared with control subjects. TMV was
significantly increased in group I (mean of FT±SD: 10±5.8,
p<0.001), but there was no significant change in group II
(mean of FT±SD: 6.12±1.26), compared with the controls.
Figure 4. Correlation between age and foveal thickness in patients
with XLRS. Black dots indicate eyes in the cystic stage, white dots
represent eyes in the atrophic stage. Green-highlighted horizontal
line represents the normal foveal thickness±SD. Red vertical line
represents the time (26 years of age) after which no cysts were
observed. Moderate negative correlation was detected between age
and foveal thickness.
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parameters (FT, TMV) of the two patient groups. According
to FT results (and similarly for TMV), the age after which the
cystic form of the disease disappeared and the atrophic form
occurs was 26 years (Figure 4).
Electroretinography: All the amplitudes of scotopic (mainly
standard combined b-waves) and photopic responses of full-
field  ERG  were  significantly  decreased  (p<0.05)  in  both
patient groups compared with values for controls (Appendix
1).  Significant  difference  (p<0.05)  between  the  two  age
groups was found for the rod b-wave amplitudes only. The
prevalence of negative type ERG was 50% (20 eyes) for all
patients, but was more common (70%) in the younger group
I (Figure 6B). There was no significant difference between the
standard  combined  b-wave  implicit  times  of  both  patient
groups and the control values. Apart from the significantly
decreased  implicit  times  of  standard  combined  a-waves
(p<0.05), the implicit times of the other measured scotopic
and photopic responses were significantly increased in both
patient groups compared with the controls (p<0.05). There
was no significant difference between the implicit times of
younger and older patient groups.
RD  of  mfERG  in  patients  was  significantly  reduced
(p<0.001) in all rings, but mainly in the central part of the
examined retinal area (corresponding to the region of foveal
schisis) compared with the controls (Figure 7). There was no
significant difference between the RD of younger and older
patient groups. Implicit times of patients were significantly
increased (p<0.05) only in the peripheral part of the examined
retinal area (rings 3–5) compared with the controls. There was
no  significant  difference  between  the  implicit  times  of
younger and older patient groups.
TABLE 2. LOCALIZATION OF RETINOSCHISIS IN RETINAL LAYERS
Groups
Place of retinoschisis Number
(eyes)
BCVA
LogMAR
(mean±SD)
Prevalence
(percent) GCL INL PRL
A + + + 13 0.47±0.14 32.5
B + + - 13 0.33±0.11 32.5
C - + - 4 0.3±0.07 10
D - + + 1 0.3 2.5
Table shows the places of retinoschisis in different retinal layers of XLRS patients detected by OCT, the number of affected
eyes,  the BCVA LogMAR values and the prevalence of different appearance forms. GCL represents ganglion cell layer, INL
indicates inner nuclear layer and PRL refers photoreceptor layer. Group A means the presence of cysts in all 3 layers, group B
means the presence of cysts in GCL and INL, group C means the presence of cysts in INL only, and group D means the presence
of cysts in INL and PRL. Group A and B were the most common appearing forms. The INL was always affected in the cystic
stage of the disease. The worst visual acuity was detected when cysts were located in all 3 layers (Group A).
TABLE 3. IDENTIFIED RS1 MUTATIONS AND THEIR PREVALENCE IN HUNGARIAN XLRS FAMILIES
Summarized are the DNA outcome of RS1 mutations in Hungarian X-linked juvenile retinoschisis pedigrees. The following
abbreviations were used: Glu is Glutamate (Glu), Arg is arginine (Arg), Gly is glycine (Gly), Cys is cysteine (Cys), His is
histidine (His), Pro is proline (Pro), Ser is serine (Ser), Leu is leucine (Leu). Prevalence based on the number of persons (n=56)
affected by XLRS. The illusory +1.79 value of prevalence is due to patient II:2 in family 4, who had two different mutations
(c.421C>T, c.574C>T) in the RS1 gene, which resulted in apparent prevalence greater than 100%. That is why the illusory +1
values of number of patients and the −1 value of total number of patients. The asterisk indicates a new mutation.
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Mutation Type of
mutation
Effect of mutation Localization Number of
carriers
Number of
patients
Number of
families
Prevalence
(percent)
c.78+1G>C splice site frameshift→
truncated protein
intron 2 2 2 1 7.14
c.214G>A missense p.Glu72Lys exon 4 5 5 2 17.86
c.418G>A missense p.Gly140Arg exon 5 4 3 2 12.5%
c.421C>T missense p.Arg141Cys exon 5 6 6+1 3 21.42+1.79
c.422G>A missense p.Arg141His exon 5 5 4 1 16.07
c.574C>T missense p.Pro192Ser exon 6 3 2 2 8.93
c.575C>T * missense p.Pro192Leu exon 6 - 1 1 1.79
c.579dupC insertion frame shift→
longer protein
exon 6 3 1 1 7.14
c.625C>T missense p.Arg209Cys exon 6 3 1 1 7.14
Total: 9 31 26–1=25 13 99.99+1.79Female  carriers  were  found  to  have  no  visual
disturbances.  Their  BCVA  (LogMAR  units)  were  0.0.  In
addition, their FT, TMV, and ERG results were within the
normal age-matched ranges.
Genetic  examination:  In  25  patients  (mean  age±SD:  26.9
years±18.5 years) and 31 female carriers (mean age±SD: 39.7
years±17.7 years) nine different mutations (eight known and
one novel) were identified by molecular genetic examination
(Figure  2,  Table  3).  Mutations,  which  included  missense
(85.7+1.79%), small frameshift insertions (7.14%), and splice
site mutations (7.14%), were detected in 100% of the patients
and carriers. Most of the mutations (92.85%) were localized
in the conservative discoidin domain, while the RS1 domain
was affected in only 7.14%. The greatest number of different
mutations (four different) was found in exon 6, while exon 5
was the most frequently (49.99%) affected part of the RS1
gene. The most commonly found mutation (23.21%) was the
c.421C>T  (p.Arg141Cys)  missense  mutation  (exon  5).
Molecular  testing  revealed  a  novel  missense  mutation  (c.
575C>T, p.Pro192Leu) in exon 6 of family 7. In addition, two
previously reported frameshift causing mutations were found:
a splice site mutation (c.78+1G>C) in intron 2 of family 2
(7.14%) and an insertion mutation (c.579dupC) in exon 6 of
family 11 (7.14%). In the II:2 patient of family 4, two different
mutations were found: a de novo (c.421C>T, Arg141Cys)
mutation  and  a  maternal  inherited  one  (c.574C>T,
Pro192Ser). The pathogenic effects of these mutations were
confirmed by excluding their presence in 100 normal male
control DNA samples.
Correlations:  Moderate  negative  correlation  (r=-0.54,
p<0.001) was detected between age and FT. When the stages
were analyzed separately, correlation was low negative for the
cystic stage (r=-0.31, p=0.14) and barely negative for the
atrophic  stage  (r=-0.24,  p=0.38)  stage  (Figure  4).  Low
negative correlation (r=-0.33, p<0.05) was detected between
age and standard combined b-wave amplitudes of full-field
ERG (Figure 6A). On the other hand BCVA LogMAR did not
Figure 5. Fundus photography of patient III:3 from family 3 with c.
214G>A missense mutation in the RS1 gene. Huge foveal schisis in
both eyes and pronounced white flecks, characteristic of fundus
albipunctatus, were seen in the right eye and mild white dots in the
left eye between the superior and inferior temporal vessels. The huge
foveal  schisis  extended  up  to  the  vascular  arcades.  Pronounced
bullous peripheral retinoschisis were detected in the inferotemporal
part in both eyes.
show any obvious correlation with age (r=-0.14, p=0.39), or
with the type of mutation (Figure 8).
DISCUSSION
The  BCVA  of  patients  was  significantly  impaired  from
childhood and, contrary to the results of Pimenides et al.,
[21] further significant impairment was not detectable with
age. Although foveal abnormalities were found in all patients
using both indirect funduscopy and OCT, foveal cystic schisis
was more often found (+10%) by the OCT, and appeared to
mainly occur in the INL and PRL retinal layers. Aside from
the presence of cysts in GCL and INL, significant impairment
of BCVA was detected if photoreceptors (PRL) were affected
also. The flat macular lamellar schisis was recognizable only
by OCT. Presence of cysts was evident in more than 3/4 of the
eyes, while the nonspecific atrophic form in the macula was
found in almost 1/4 of the eyes. The high overall prevalence
of the cystic form in these results is undoubtedly due to the
relatively young age of our patients (mean 24.5±16.6 years).
The  most  common  phenotype  of  the  disease  was  the
Figure 6. Correlation between age and standard combined b-wave
amplitudes and between age and standard combined b/a-wave ratio
in patients with XLRS. Black points represent eyes. A: Low negative
correlation was detected between age and standard combined b-wave
amplitudes of full-field ERG. B: There was no correlation detectable
between age and standard combined b/a-wave ratio of full-field ERG.
Negative type ERG (b/a ratio ≤1) was detected in half of the group
of eyes.
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2327association of foveal cysts and macular lamellar schisis (type
3). The prevalence of peripheral retinoschisis was found to be
lower than generally reported in the literature [4]. White flecks
and  dots,  characteristic  of  fundus  albipunctatus,  were
associated with the biggest foveal and peripheral retinoschisis.
Lesions that are like that seen in fundus albipunctatus are a
known, uncommon fundus appearance in XLRS [22]. Our
calculations  confirmed  that  white  lesions  seemed  to  be
identical to palisades visible by OCT between the splitted
retinal layers.
Patients’  OCT  images  differed  greatly,  and  a  large
interocular and intrafamilial variability was found. The time-
course  of  the  disease  can  be  characterized  by  the  OCT
parameters (Figure 4). This study is the first to present the
exact time of changing from the cystic to atrophic stage of the
disease. Before 26 years of age, large inner nuclear central
cysts  (with  significantly  elevated  FT  and  TMV)  were
characteristic (Figure 1C). After 26 years of age a nonspecific
foveal  and  perifoveal  atrophy  with  unchanged  parafoveal
retinal thickness was more common (Figure 1D). In older age
the whole macula was markedly atrophic.
Regarding the change from the cystic to atrophic stage
(after  26  years),  a  moderate  negative  correlation  was
detectable between age and FT; but within each stage there
was only low and little negative correlation with age (Figure
4). Excluding the remarkable FT change about 26 years of age
the  aforedescribed  results  showed  a  rather  limited  age
dependency  of  FT  alterations.  Examining  the  possible
functional effects of the morphological changes found by
OCT between the younger and older patient groups, there
were no significant differences in BCVA, in amplitudes and
implicit times of full-field (except the rod b-wave amplitudes)
and  mfERGs.  The  lack  of  correlation  between  OCT  and
BCVA was probably due to inability to fixate and the common
eccentric  fixation.  As  with  other  reports,  we  found  the
changing of central macular region visible by OCT was not
accompanied by further visual impairment [12,23].
In two boys (family 1 IV:2, 12 years of age; family 2 III:
1, 7 years of age) improvement of BCVA (three lines on the
Snellen chart) was detected during a one-year follow-up, but
without any notable structural changes (OCT), or functional
improvement (ERG) of the retina. This was probably due to
more efficient use of the ectopic parafoveal retina, and would
occur only in young patients as a result of the plasticity of the
developing visual system.
While previous research has demonstrated that RS1 is
synthesized mainly in and secreted from the inner segment of
photoreceptors [6,24–26], Takada et al. identified in healthy
mouse retina that RS1 mRNA was expressed in the ganglion
cells first, and later in all remarkable cells locally in the outer
layers of the retina [26]. This molecular mechanism explains
why retinoschisis may affect several different layers of the
retina [26]. In agreement with the latest publications we found
retinoschisis mainly in the INL (Müller and bipolar cells) and
in  the  PRL,  using  OCT  [7,9,12,27].  The  dysfunctional,
defective  RS1  may  accumulate  in  these  layers,  both
intracellular  and  extracellular  layers,  leading  to  cysts  and
schisis  [3,21].  In  cases  of  nonspecific  foveal  atrophy,
electrophysiological and molecular genetic examinations are
needed to confirm the diagnosis.
Nonspecifically  all  the  amplitudes  of  scotopic  and
photopic  responses  of  full-field  ERG  were  significantly
decreased in both patient groups compared with the controls.
The only appropriate clinical sign to confirm the diagnosis of
XLRS was the pronouncely decreased standard combined b-
wave amplitudes, and in advanced cases negative type full-
field  ERGs  (in  50%  of  patients).  Significant  difference
between full-field ERG responses of the two patient groups
was  found  in  case  rod  b-wave  amplitudes  only.  Standard
Figure 7. Mean values of response densities and implicit times of
mfERGs for five eccentric rings in controls, carriers, and patients.
Gray  area  represents  standard  deviation.  Red  lines  highlight
significant  changes  compared  with  the  controls.  A:  Response
densities of patients were significantly decreased (p<0.05) in all rings
(especially in central rings) compared with the controls, with no
significant  difference  found  between  the  two  patient  groups.  B:
Implicit times of patients were significantly increased (p<0.05) only
in  the  peripheral  part  of  the  examined  retinal  area  (rings  3–5)
compared with the controls, with no significant difference observed
between the two patient groups. In carriers, response densities and
implicit times were within the normal range.
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2328combined b-wave amplitudes of full-field ERG showed a low
Figure 8. Distribution of different mutations with relevant BCVA
(A), FT (B), standard combined b-wave amplitudes of full field ERG
(C),  and  age.  Age  (yrs)  is  showed  by  numbers  beside  symbols
characterizing the type of mutations in each eye. Mean values of
controls are shown by the horizontal black broken line and the ±SD
by a horizontal dark gray stripe. A: BCVA values belonging to a
certain mutation were variable irrespective of age. The best and the
worst BCVA belonged to two adjoining mutations (c.422G>A, c.
421C>T). B: FT values change irrespectively of the type of mutation,
but after 26 years of age, almost exclusively the atrophic form is
detectable by OCT. C: The decrease of standard combined b-wave
amplitudes  belonging  to  a  certain  type  of  mutations  were  also
different, irrespective of age.
negative correlation with age, while BCVA LogMAR did not
show  any  obvious  correlation  with  age  or  mutation  type
(Figure 8).
The mainly centrally decreased P1 amplitudes of mfERG
probably indicate the lack of functioning cells in the central
part  of  the  foveal  schisis,  while  the  mainly  peripherally
delayed implicit times may be caused by the functionally
damaged but still living cells. Previous results, based on ERG
examinations, found Müller cells to be primary locations of
the disease [28]. Recent results demonstrate that the mfERG
(FOK) P1-waves originate mainly from ON- and OFF-bipolar
cells, with a smaller contribution from cone photoreceptors
[28]. Thus bipolar cells seem to be affected rather than Müller
cells in which, furthermore, no RS immunoreactivity was
detected [24,26]. Our abnormal ERG responses also suggest
that the retinal damage affects mainly the INL and the PRL
layers,  where  the  biggest  schisis  was  found  by  OCT  and
where, normally, the RS1 can be detected in the greatest
amount [12,24,25]. Flat schisis and functional impairment
was detected by OCT and mfERG in a greater part of the retina
than would have been expected by funduscopy.
To identify patients with uncertain diagnosis and carriers
without any symptoms, molecular genetic examinations are
necessary  (90%  certainty)  [29].  On  the  basis  of  previous
genetic examinations, most of the mutations are missense
mutations  and  localized  to  exons  4–6  of  RS1  within  the
discoidin domain (dmd) [2]. Exons 1–3 tend to have mainly
translation-truncating nonsense mutations [15].
This  article  is  the  first  study  to  estimate  the  genetic
background of patients with XLRS in Hungary. All the tested
patients and carriers were found to have RS1 coding or splice
site  mutations.  Most  of  the  mutations  were  found  to  be
localized in the conservative discoidin domain, which caused
protein  misfolding  and  finally  retention  of  RS1  in  the
endoplasmic reticulum [18]. The remaining mutations were
localized in the RS1 domain, which interfered with the normal
oligomerization of RS1 [18]. Mutations in the leader sequence
(not found in our study) prevented the translocation of the
polypeptide  chain  across  the  endoplasmic  reticulum
membrane as part of the secretion process [18]. In each case
the mutant RS1 was unable to function as an extracellular cell-
adhesion protein.
Of  the  nine  different  mutations  found,  the  c.421C>T
missense mutation (exon 5) was detected most frequently.
That a de novo mutation (c.421C>T) was found in patient II:
2 of family 4 together with the already known disease-causing
variant (c.574C>T, inherited from his mother), illustrates the
remarkable new mutation rate of RS1 and the high mutation
heterogeneity of the disease. Although the aforedescribed case
with  simultaneous  presence  of  two  mutations  and  the
consequent two AAs substitution led to pronounced change
in the tertiary structure of the RS1 (based on the CBS CPH
model), neither the clinical condition nor the examination
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2329results were affected more than in those cases with separate
presence  of  these  two  mutations.  It  is  presumed  the  two
mutations led to intracellular degradation of the RS1 even
separately  [21,30].  Considering  that  female  carriers  are
unaffected, it seems that the absence of a functional RS1,
rather than the presence of a mutant protein, was responsible
for retinoschisis in affected males [31].
We highlight the fact that a novel missense mutation (c.
575C>T) was found in family 7. Although missense, insertion,
and  splice  site  mutations  have  also  been  identified,  no
genotype-phenotype  correlation  could  be  detected.  The
relatively  low  number  of  our  samples,  the  intracellular
degradation and lack of secretion of mutant RS1 (loss of
protein  function)  could  explain  why  phenotypes  are
independent of the position or type of mutation [3,21,30]. The
great phenotype variability in the case of the same mutation
within one family, or between two eyes of the same person,
presumably reflects the influence of other factors or genes
[32].
Contrary to the data of the Retinoschisis database (dmd;
exon 4: 42.7%; exon 5: 16.3%; exon 6: 26.9%), the frequency
of various types of mutations per exons and introns were
different in these Hungarian patients (exon 4: 11.1%; exon 5:
33.3%; exon 6: 44.4%; and intron 2: 11.1%). Two mutation
hot  spots  were  found:  between  c.418–422  in  exon  5  and
between c.574–579 in exon 6. Almost 70% of the mutations
were within this part of RS1.
Although XLRS is one of the most frequent causes of
juvenile macular degeneration, it is still underdiagnosed and
often  misdiagnosed.  Serious  visual  deterioration  can  be
prevented by regular follow-up and surgical intervention in
case  of  sudden  retinal  complications.  Molecular  genetic
examinations are of particular importance to identify carriers
without any symptoms and timely genetic counseling may
help in family planning decisions. Although there is no current
therapy for the disease, the successful gene therapy performed
in mice brings hope for the future [27,31,33].
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2331Appendix 1. Clinical data of members
A:  Summarized  are  the  BCVA,  OCT,  full-field,  and
multifocal ERG values of each XLRS patients. In case of each
patient the upper line represents the right eye, while the lower
line represents the left eye. St. combined indicates standard
combined full-field ERG response. B: Table shows mean
values±standard  deviation  of  BCVA  logMAR,  OCT,  and
ERG examinations in controls, carriers, and the two patient
groups. Grp indicates group. To access the data, click or select
the words “Appendix 1.” This will initiate the download of a
compressed (pdf) archive that contains the file.
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